Paper199129
Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data.
Rifkin A and 2 others. Arch Gen Psychiatry, 1977. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data. Papers, record 199129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/199129
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aftercare | Major topic |
| Fluphenazine | Major topic |
| Schizophrenia | Major topic |
| Administration, Oral | |
| Basal Ganglia Diseases | |
| Chronic Disease | |
| Double-Blind Method | |
| Humans | |
| Injections | |
| Placebos | |
| Psychiatric Status Rating Scales | |
| Remission, Spontaneous |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,831,918 | Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. | Ther Adv Psychopharmacol | 2024 | https://conductscience.org/library/papers/38831918 | PubMed |
| 35,524,620 | Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants. | World Psychiatry | 2022 | https://conductscience.org/library/papers/35524620 | PubMed |
| 32,840,872 | Maintenance treatment with antipsychotic drugs for schizophrenia. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32840872 | PubMed |
| 29,893,410 | Fluphenazine (oral) versus placebo for schizophrenia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29893410 | PubMed |
| 26,293,744 | The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics. | CNS Drugs | 2015 | https://conductscience.org/library/papers/26293744 | PubMed |
| 25,654,768 | Fluphenazine decanoate (depot) and enanthate for schizophrenia. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25654768 | PubMed |
| 23,861,067 | Fluphenazine (oral) versus placebo for schizophrenia. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23861067 | PubMed |
| 22,966,436 | Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. | Schizophr Res Treatment | 2012 | https://conductscience.org/library/papers/22966436 | PubMed |
| 6,111,128 | Antipsychotic drugs in community-based sheltered-care homes. | Soc Sci Med Med Psychol Med Sociol | 1980 | https://conductscience.org/library/papers/6111128 | PubMed |
| 280,396 | What's new in the psychopharmacology of schizophrenia. | Bull N Y Acad Med | 1978 | https://conductscience.org/library/papers/280396 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/199129
GET https://conductscience.org/api/papers/v1/199129/authors